NanoViricides (NYSE-A:NNVC) announced that it will present at the PODD 2025 Conference in Boston on October 27 at 3 pm.
CEO Dr Anil Diwan will provide updates on the company’s broad-spectrum antiviral drug pipeline and platform technologies, including licensing opportunities.
NanoViricides is a clinical-stage company developing antiviral treatments designed to prevent viral escape.